99 related articles for article (PubMed ID: 26600503)
41. Differential expression of adhesion molecules (CD44, ICAM-1 and LFA-3) in cancer cells grown in monolayer or as multicellular spheroids.
Rainaldi G; Calcabrini A; Arancia G; Santini MT
Anticancer Res; 1999; 19(3A):1769-78. PubMed ID: 10470114
[TBL] [Abstract][Full Text] [Related]
42. [Anti-tumor and immune-modulating effect of
Chen L; Jin T; Ning C; Wang S; Wang L; Lin J
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):241-248. PubMed ID: 30890515
[TBL] [Abstract][Full Text] [Related]
43. Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns.
Cai J; Zhao XL; Liu AW; Nian H; Zhang SH
Phytomedicine; 2011 Mar; 18(5):366-73. PubMed ID: 20850954
[TBL] [Abstract][Full Text] [Related]
44. Carboxymethyl chitosan represses tumor angiogenesis in vitro and in vivo.
Jiang Z; Han B; Li H; Yang Y; Liu W
Carbohydr Polym; 2015 Sep; 129():1-8. PubMed ID: 26050881
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
46. Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo.
Enomoto H; Nakamura H; Liu W; Iwata Y; Nishikawa H; Takata R; Yoh K; Hasegawa K; Ishii A; Takashima T; Sakai Y; Aizawa N; Ikeda N; Iijima H; Nishiguchi S
Anticancer Res; 2015 Dec; 35(12):6475-9. PubMed ID: 26637859
[TBL] [Abstract][Full Text] [Related]
47. G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high‑dose cisplatin-induced nephrotoxicity.
Li L; Khan MN; Li Q; Chen X; Wei J; Wang B; Cheng JW; Gordon JR; Li F
Oncol Rep; 2015 Feb; 33(2):751-7. PubMed ID: 25504010
[TBL] [Abstract][Full Text] [Related]
48. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of antitumour activity of tea carbohydrate polymers in hepatocellular carcinoma animals.
Chen B; Zhou W; Ning M; Wang Z; Zou L; Zhang H; Wang Q
Int J Biol Macromol; 2012 May; 50(4):1103-8. PubMed ID: 22406869
[TBL] [Abstract][Full Text] [Related]
50. [Effects of Rapamycin on angiogenesis and tumor progression in human hepatocellular carcinoma implantation mice].
Zhang J; Li H; Wang GS; Jiang N; Yang Y; Chen GH
Zhonghua Wai Ke Za Zhi; 2009 Sep; 47(18):1403-5. PubMed ID: 20092777
[TBL] [Abstract][Full Text] [Related]
51. [Induction of lymphangiogenesis by mouse ascites hepatoma cell H22 in vitro].
Zhou HZ; Gu XM; Hu M; Liu HC
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):39-42. PubMed ID: 12678985
[TBL] [Abstract][Full Text] [Related]
52. The inhibitory effect of celecoxib on mouse hepatoma H22 cell line on the arachidonic acid metabolic pathway.
Xu Z; Zhang M; Lv X; Xiang D; Zhang X; Chen L
Biochem Cell Biol; 2010 Aug; 88(4):603-9. PubMed ID: 20651831
[TBL] [Abstract][Full Text] [Related]
53. [Effect of HMGB1 on invasion and migration of human hepatoma cell line HepG2 and its mechanism].
Wang C; Tang C; Chang X; Li Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1159-62. PubMed ID: 24200063
[TBL] [Abstract][Full Text] [Related]
54. MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA.
Lu Z; Zhang W; Gao S; Jiang Q; Xiao Z; Ye L; Zhang X
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):8-13. PubMed ID: 26549227
[TBL] [Abstract][Full Text] [Related]
55. [Effect of Jianpi Jiedu decoction to PTEN/ERK1 of athymic mice with hepatocellular carcinoma].
Sun B; Zhou H; Deng Y; Huang H; Chen Z; Zhang S
Zhongguo Zhong Yao Za Zhi; 2009 May; 34(9):1144-8. PubMed ID: 19685755
[TBL] [Abstract][Full Text] [Related]
56. [Comparison of antitumor effects of dendritic cells modified with different forms of hepatocellular cancer antigens].
He LX; Zhang GM; Feng ZH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):100-2, 117. PubMed ID: 15629095
[TBL] [Abstract][Full Text] [Related]
57. 4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis.
Piccioni F; Fiore E; Bayo J; Atorrasagasti C; Peixoto E; Rizzo M; Malvicini M; Tirado-González I; García MG; Alaniz L; Mazzolini G
Glycobiology; 2015 Aug; 25(8):825-35. PubMed ID: 25882295
[TBL] [Abstract][Full Text] [Related]
58. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
59. Efficacy of intra-tumor injection of Xiao-Zhi-Ling on transplanted hepatoma in rats.
Lu Y; Wu LQ
World J Gastroenterol; 2003 Sep; 9(9):2121-4. PubMed ID: 12970920
[TBL] [Abstract][Full Text] [Related]
60. Experimental study on therapeutic effect of in vivo expression of Cell I-Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma.
Zhang GM; Yang Y; Huang B; Xiao H; Li D; Feng ZH
World J Gastroenterol; 2003 Sep; 9(9):1940-5. PubMed ID: 12970880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
